Requires health insurance coverage for hair headpieces for patients receiving chemotherapy treatment for cancer.
Impact
The bill, upon enactment, will impact all health benefit plans provided by various carriers in New Jersey, including individual policies, small and large group health plans, and hospital service corporations. This legislation is intended to align the provisions for headpieces with those already in place for prostheses, thus standardizing and expanding coverage within the state's healthcare framework.
Summary
Assembly Bill A1376 aims to mandate that health insurance policies provide coverage for headpieces, such as wigs made of human or artificial hair, for patients undergoing chemotherapy treatment for cancer. This legislation underscores the importance of addressing hair loss as a significant concern for cancer patients, thereby enhancing their overall quality of life during challenging treatment periods. The bill specifies that coverage will be contingent upon a written recommendation from the treating physician, asserting the medical necessity of the headpiece for the patient.
Contention
While the bill is welcomed by many advocates who see it as a compassionate response to the physical and emotional challenges faced by cancer patients, there may be concerns regarding the financial implications for insurance providers. Critics, particularly those in the insurance industry, might argue that mandating such coverage could lead to increased premiums for health plans. Furthermore, the necessity for a physician's recommendation could spark debates about accessibility, with some fearing it may limit coverage for individuals who would benefit from a headpiece but do not have a straightforward path to obtaining such recommendations.
Mandates insurance coverage for scalp cooling treatments for cancer patients undergoing chemotherapy to prevent hair loss during chemotherapy treatments.
Mandates insurance coverage for scalp cooling treatments for cancer patients undergoing chemotherapy to prevent hair loss during chemotherapy treatments.
Mandates insurance coverage for scalp cooling treatments for breast cancer patients undergoing chemotherapy to prevent hair loss during chemotherapy treatments.
Requires health insurance coverage of scalp cooling systems in connection with cancer chemotherapy treatment; requires physicians to inform patients of scalp cooling therapy.
Requires health insurance coverage of scalp cooling systems in connection with cancer chemotherapy treatment; requires physicians to inform patients of scalp cooling therapy.